Literature DB >> 14999158

Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and research.

Uriel Halbreich1.   

Abstract

A review of the literature demonstrates that the incidence of new mental disorders and their prevalence during pregnancy is similar to the 12-month incidence of mental disorders in women during other periods of their lives. The prevalence of severe mood, behavior, and cognitive symptoms during pregnancy is rather high. Severe mental symptoms during pregnancy have been reported to be associated with an increased rate of complications during pregnancy and delivery, preterm deliveries, low birth weight, a higher rate of postpartum depression, and a longer-term impact on the offspring's development. Several pre-pregnancy risk factors to develop dysphoric symptoms have been reported, but their utility for primiparous women with no previous history of mental disorders is unclear. The association of mental symptoms with general symptoms and biological changes during pregnancy is also unclear. Given the short- and long-term impact of dysphoric symptoms and stress during pregnancy on mother and child, efficacious, efficient, and safe prevention and treatment modalities are essential and achievable. Clarification of the nature and phenotyping of mental and general symptoms during pregnancy is an important step for the development of effective interventions.

Entities:  

Mesh:

Year:  2004        PMID: 14999158     DOI: 10.1017/s109285290000897x

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  10 in total

Review 1.  Implications of timing of maternal depressive symptoms for early cognitive and language development.

Authors:  Sara L Sohr-Preston; Laura V Scaramella
Journal:  Clin Child Fam Psychol Rev       Date:  2006-03

Review 2.  Serotonin reuptake inhibitor-induced perinatal complications.

Authors:  Salvatore Gentile
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 3.  The safety of newer antidepressants in pregnancy and breastfeeding.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Depressive symptoms among reservation-based pregnant American Indian adolescents.

Authors:  Golda S Ginsburg; Elena Varipatis Baker; Britta C Mullany; Allison Barlow; Novalene Goklish; Ranelda Hastings; Audrey E Thurm; Kristen Speakman; Raymond Reid; John Walkup
Journal:  Matern Child Health J       Date:  2008-05-03

Review 5.  Pregnancy and depression: exploring a new potential treatment option.

Authors:  Deborah R Kim; Juan Gonzalez; John P O'Reardon
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

6.  Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine.

Authors:  Monica S Paz; Lynne M Smith; Linda L LaGasse; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2008-12-03       Impact factor: 3.763

Review 7.  Perinatal depression: treatment options and dilemmas.

Authors:  Teri Pearlstein
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 8.  Suicidal mothers.

Authors:  Salvatore Gentile
Journal:  J Inj Violence Res       Date:  2011-07

9.  Interventions to treat mental disorders during pregnancy: A systematic review and multiple treatment meta-analysis.

Authors:  Leontien M van Ravesteyn; Mijke P Lambregtse-van den Berg; Witte J G Hoogendijk; Astrid M Kamperman
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

10.  The Psychological Impact of the Coronavirus Disease 2019 Pandemic on Pregnant Women in China.

Authors:  Zheng Zheng; Ruoxi Zhang; Tao Liu; Pei Cheng; Yanhong Zhou; Weicong Lu; Guiyun Xu; Kwok-Fai So; Kangguang Lin
Journal:  Front Psychiatry       Date:  2021-07-02       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.